litlas
ログインアカウント作成

Philip J. Barter

1978–2024 年に発表

138
論文数
45,333
被引用数
100
h 指数
138
i10 指数

被引用数

Philip J. Barter の年別被引用数1965 年: 被引用 1 件1980 年: 被引用 8 件1981 年: 被引用 7 件1982 年: 被引用 21 件1983 年: 被引用 9 件1984 年: 被引用 18 件1985 年: 被引用 11 件1986 年: 被引用 7 件1987 年: 被引用 6 件1988 年: 被引用 13 件1989 年: 被引用 22 件1990 年: 被引用 20 件1991 年: 被引用 18 件1992 年: 被引用 18 件1993 年: 被引用 25 件1994 年: 被引用 18 件1995 年: 被引用 21 件1996 年: 被引用 20 件1997 年: 被引用 20 件1998 年: 被引用 35 件1999 年: 被引用 62 件2000 年: 被引用 68 件2001 年: 被引用 61 件2002 年: 被引用 94 件2003 年: 被引用 102 件2004 年: 被引用 108 件2005 年: 被引用 146 件2006 年: 被引用 201 件2007 年: 被引用 224 件2008 年: 被引用 393 件2009 年: 被引用 310 件2010 年: 被引用 366 件2011 年: 被引用 449 件2012 年: 被引用 452 件2013 年: 被引用 482 件2014 年: 被引用 491 件2015 年: 被引用 460 件2016 年: 被引用 395 件2017 年: 被引用 357 件2018 年: 被引用 337 件2019 年: 被引用 1,148 件2020 年: 被引用 1,113 件2021 年: 被引用 1,165 件2022 年: 被引用 1,021 件2023 年: 被引用 799 件2024 年: 被引用 1,088 件2025 年: 被引用 597 件2026 年: 被引用 38 件1966〜1979 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,785 件、この内訳の 22.2%中国: 引用元論文 1,291 件、この内訳の 7.6%イギリス: 引用元論文 1,251 件、この内訳の 7.3%オーストラリア: 引用元論文 796 件、この内訳の 4.7%イタリア: 引用元論文 741 件、この内訳の 4.3%カナダ: 引用元論文 728 件、この内訳の 4.3%オランダ: 引用元論文 687 件、この内訳の 4%ドイツ: 引用元論文 674 件、この内訳の 4%フランス: 引用元論文 513 件、この内訳の 3%スウェーデン: 引用元論文 434 件、この内訳の 2.5%日本: 引用元論文 432 件、この内訳の 2.5%スペイン: 引用元論文 425 件、この内訳の 2.5%
0%22.2%その他 31.1%

機関

分野

  • Medicine67.4%
  • Biochemistry, Genetics and Molecular Biology21.1%
  • Nursing3.6%
  • Immunology and Microbiology2.7%
  • Neuroscience1.3%
  • Health Professions0.7%
  • その他3.2%

トピック

  • Lipoproteins and Cardiovascular Health10.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins9.7%
  • Cancer, Lipids, and Metabolism3.1%
  • Cholesterol and Lipid Metabolism3%
  • Genetic Associations and Epidemiology2.7%
  • Adipokines, Inflammation, and Metabolic Diseases2.5%
  • その他68.9%

共著者

全論文

検索で開く
  1. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

    著者: Robert Ross, Ian J. Neeland, Shizuya Yamashita, Iris Shai, Jaap Seidell, Paolo Magni, Raúl D. Santos, Benoît J. Arsenault, Ada Cuevas, Frank B. Hu, Bruce A. Griffin, Alberto Zambon, Philip J. Barter, Jean‐Charles Fruchart, Robert H. Eckel, Yūji Matsuzawa, Jean‐Pierre Després - Nature Reviews Endocrinology 2020 被引用: 1,887

  2. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

    著者: Ian J. Neeland, Robert Ross, Jean‐Pierre Després, Yūji Matsuzawa, Shizuya Yamashita, Iris Shai, Jaap Seidell, Paolo Magni, Raúl D. Santos, Benoît J. Arsenault, Ada Cuevas, Frank B. Hu, Bruce A. Griffin, Alberto Zambon, Philip J. Barter, Jean‐Charles Fruchart, Robert H. Eckel - The Lancet Diabetes & Endocrinology 2019 被引用: 1,508

  3. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    著者: Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen - JAMA 2020 被引用: 982

  4. Effects of Torcetrapib in Patients at High Risk for Coronary Events

    著者: Philip J. Barter, Mark J. Caulfield, Mats Eriksson, Scott M. Grundy, John J.P. Kastelein, Michel Komajda, José López‐Sendón, Lori Mosca, Jean‐Claude Tardif, David D. Waters, Charles L. Shear, James H. Revkin, Kevin A. Buhr, Marian R. Fisher, Alan R. Tall, Bryan Brewer - New England Journal of Medicine 2007 被引用: 3,144

  5. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    著者: Gregory G. Schwartz, Anders Olsson, Markus Abt, Christie M. Ballantyne, Philip J. Barter, Jochen Brumm, Bernard Chaitman, Ingar Holme, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Hardi Mundl, Stephen J. Nicholls, Prediman K. Shah, Jean‐Claude Tardif, R. Scott Wright - New England Journal of Medicine 2012 被引用: 2,035

  6. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    著者: A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, Philip J. Barter, H Bryan Brewer, Keith A.A. Fox, C. Michael Gibson, Christopher B. Granger, Venu Menon, Gilles Montalescot, Daniel Rader, Alan R. Tall, Ellen McErlean, Kathy Wolski, Giacomo Ruotolo, Burkhard Vangerow, Govinda J. Weerakkody, Shaun G. Goodman, Diego Conde, Darren K. McGuire, José Carlos Nicolau, José L. Leiva-Pons, Yves Pesant, Weimin Li, David Kandath, Simon Kouz, Naeem Tahirkheli, Denise Mason, Steven E. Nissen - New England Journal of Medicine 2017 被引用: 798

  7. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

    著者: John C. LaRosa, Scott M. Grundy, David D. Waters, Charles L. Shear, Philip J. Barter, Jean‐Charles Fruchart, Antonio M. Gotto, Heiner Greten, John J.P. Kastelein, James Shepherd, Nanette K. Wenger - New England Journal of Medicine 2005 被引用: 3,504

  8. Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    著者: Stephen J. Nicholls, Christie M. Ballantyne, Philip J. Barter, M. John Chapman, Raimund M. Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Marilyn Borgman, Kathy Wolski, Steven E. Nissen - New England Journal of Medicine 2011 被引用: 892

  9. Dysfunctional HDL and atherosclerotic cardiovascular disease

    著者: Robert S. Rosenson, H. Bryan Brewer, Benjamin J. Ansell, Philip J. Barter, M. John Chapman, Jay W. Heinecke, Anatol Kontush, Alan R. Tall, Nancy R. Webb - Nature Reviews Cardiology 2015 被引用: 800

  10. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    著者: Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Lisa Holland, Kate Wilson, Jane Armitage, Charlie Harper, David Preiss, Alistair Roddick, Anthony Keech, John Simes, Rory Collins, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Borislava Mihaylova, Rachel O’Connell, Pierre Amarenco, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Jackie Bosch, Louise Bowman, Eugene Braunwald, Christopher P. Cannon, Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet ほか 28 名 - The Lancet 2022 被引用: 246

  11. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

    著者: Josée Dupuis, the MAGIC investigators, Claudia Langenberg, Inga Prokopenko, Richa Saxena, Nicole Soranzo, Anne Jackson, Eleanor Wheeler, Nicole L. Glazer, Nabila Bouatia‐Naji, Anna L. Gloyn, Cecilia M. Lindgren, Reedik Mägi, Andrew P. Morris, Joshua C. Randall, Toby Johnson, Paul Elliott, Denis Rybin, Guðmar Þorleifsson, Valgerður Steinthórsdóttir, Peter Henneman, Harald Grallert, Abbas Dehghan, Jouke‐Jan Hottenga, C. Franklin, Pau Navarro, Kijoung Song, Anuj Goel, John R. B. Perry, Josephine M. Egan, Taina K. Lajunen, Niels Grarup, Thomas Sparsø, Alex S. F. Doney, Benjamin F. Voight, Heather M. Stringham, Man Li, Stavroula Kanoni, Peter Shrader, Christine Cavalcanti-Proença, Meena Kumari, Lu Qi, Nicholas J. Timpson, Christian Gieger, Katja K.H. Aben, Ghislain Rocheleau, Erik Ingelsson, Ping An, Jeffrey R. O’Connell, Jian’an Luan, Amanda Elliott, Steven A. McCarroll, Felicity Payne, Rosa Maria Roccasecca, François Pattou, Praveen Sethupathy, Kristin Ardlie, Yavuz Ariyürek, Beverley Balkau, Philip J. Barter, John Beilby, Yoav Ben‐Shlomo, Rafn Benediktsson, Amanda J. Bennett, Richard N. Bergman, Murielle Bochud, Eric Boerwinkle, Amélie Bonnefond, Lori L. Bonnycastle, Knut Borch‐Johnsen, Yvonne Böttcher, Eric J. Brunner, Suzannah J. Bumpstead, G. Charpentier, Yii‐Der Ida Chen, Peter S. Chines, Robert Clarke, Lachlan Coin, Matthew N. Cooper, Marilyn C. Cornelis, Gabe Crawford, Laura Crisponi, Ian N.M. Day, Eco J. C. de Geus, Jérôme Delplanque, Christian Dina, Michael R. Erdos, Annette C. Fedson, Antje Fischer‐Rosinsky, Nita G. Forouhi, Caroline S. Fox, Rune R. Frants, Maria Grazia Franzosi, Pilar Galán, Mark O. Goodarzi, J. Graessler, Christopher J. Groves, Scott M. Grundy, Rhian Gwilliam, Ulf Gyllensten ほか 163 名 - Nature Genetics 2010 被引用: 2,228

  12. Antiinflammatory Properties of HDL

    著者: Philip J. Barter, Stephen J. Nicholls, Kerry-Anne Rye, G.M. Anantharamaiah, Mohamad Navab, Alan M. Fogelman - Circulation Research 2004 被引用: 1,365

  13. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    著者: Christina Reith, David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Charlie Harper, Lisa Holland, Kate Wilson, Alistair Roddick, Christopher P. Cannon, Robert Clarke, Helen M. Colhoun, Paul N. Durrington, Shinya Goto, G. A. Hitman, G. Kees Hovingh, J. Wouter Jukema, Wolfgang Köenig, Ian C. Marschner, Borislava Mihaylova, Connie B. Newman, Jeffrey L Probsfield, Paul M. Ridker, Marc S. Sabatine, Naveed Sattar, Gregory G. Schwartz, Luigi Tavazzi, Andrew Tonkin, Stella Trompet, Harvey D. White, Salim Yusuf, Jane Armitage, Anthony Keech, John Simes, Rory Collins, Colin Baigent, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Rachel O’Connell, Pierre Amarenco, Hiroyuki Arashi, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Gerard J Blauw, Jackie Bosch, Louise Bowman, Eugene Braunwald, Richard Bulbulia, Robert Byington, Michael Clearfield, Stuart M. Cobbe, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, Uri Goldbourt, David Gordon, Antonio M. Gotto, Richard Grimm, A Gupta, C. Hawkins, Richard Haynes, Hallvard Holdaas, Jemma C. Hopewell, Alan G. Jardine, John J.P. Kastelein, Sharon Kean, Patricia M. Kearney, George D. Kitas, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis ほか 32 名 - The Lancet Diabetes & Endocrinology 2024 被引用: 137

  14. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

    著者: Antonio J. Vallejo‐Vaz, Rana Fayyad, S. Matthijs Boekholdt, G. Kees Hovingh, John J.P. Kastelein, Shari Melamed, Philip J. Barter, David D. Waters, Kausik K. Ray - Circulation 2018 被引用: 195

  15. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

    著者: Fatiha Tabet, Kasey C. Vickers, Luisa Torres, Carrie B. Wiese, Bassem M. Shoucri, Gilles Lambert, Claire Catherinet, Leonel Prado-Lourenço, Michael G. Levin, Seth G. Thacker, Praveen Sethupathy, Philip J. Barter, Alan T. Remaley, Kerry-Anne Rye - Nature Communications 2014 被引用: 418

  16. Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

    著者: G. Kees Hovingh, John J.P. Kastelein, Sander J. H. van Deventer, Patrick Round, J. Ford, Danish Saleheen, Daniel J. Rader, H. Bryan Brewer, Philip J. Barter - The Lancet 2015 被引用: 238

  17. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

    著者: Raúl D. Santos, Samuel S. Gidding, Robert A. Hegele, Marina Cuchel, Philip J. Barter, Gerald F. Watts, Seth J. Baum, Alberico L. Catapano, M. John Chapman, Joep C. Defesche, Emanuela Folco, Tomáš Freiberger, Jacques Genest, G. Kees Hovingh, Mariko Harada‐Shiba, Steve E. Humphries, Ann S Jackson, Pedro Mata, Patrick M. Moriarty, Frederick J. Raal, Khalid Al‐Rasadi, Kausik K. Ray, Zelijko Reiner, Eric J.G. Sijbrands, Shizuya Yamashita - The Lancet Diabetes & Endocrinology 2016 被引用: 418

  18. High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

    著者: Gillian Cockerill, Kerry‐Anne Rye, Jennifer R. Gamble, Mathew A. Vadas, Philip J. Barter - Arteriosclerosis Thrombosis and Vascular Biology 1995 被引用: 777

  19. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

    著者: Philip J. Barter, Antonio M. Gotto, John C. LaRosa, Jaman Maroni, Michael Szarek, Scott M. Grundy, John J.P. Kastelein, Vera Bittner, Jean‐Charles Fruchart - New England Journal of Medicine 2007 被引用: 1,618

  20. Cholesteryl Ester Transfer Protein

    著者: Philip J. Barter, H Bryan Brewer, M. John Chapman, Charles H. Hennekens, Daniel J. Rader, Alan R. Tall - Arteriosclerosis Thrombosis and Vascular Biology 2003 被引用: 867

  21. Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER

    著者: Björn W. Karlson, Olov Wiklund, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter - European Heart Journal - Cardiovascular Pharmacotherapy 2016 被引用: 145

  22. The emerging role of HDL in glucose metabolism

    著者: Brian G. Drew, Kerry‐Anne Rye, Stephen J. Duffy, Philip J. Barter, Bronwyn A. Kingwell - Nature Reviews Endocrinology 2012 被引用: 325

  23. Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

    著者: John J.P. Kastelein, Wim A. van der Steeg, Ingar Holme, Michael Gaffney, Nilo B. Cater, Philip J. Barter, Prakash Deedwania, Anders Olsson, S. Matthijs Boekholdt, David A. DeMicco, Michael Szarek, John C. LaRosa, Terje R. Pedersen, Scott M. Grundy - Circulation 2008 被引用: 472

  24. Cholesteryl ester transfer protein and its inhibitors

    著者: Sudichhya Shrestha, Ben J. Wu, L. Guiney, Philip J. Barter, Kerry‐Anne Rye - Journal of Lipid Research 2018 被引用: 99